Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterNo recent work listed

Charlotte Lemech

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5399-9431; OpenAlex author ID A5027672041. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2023: 2 papers

Papers 2

  1. Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer. Co-author DOI 10.1056/nejmoa2208470↗
  2. Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colo… Co-author DOI 10.1136/jitc-2022-006136↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David Goldstein · 1 shared paper, 2023 · strength 0.16
  2. Nick Pavlakis · 1 shared paper, 2023 · strength 0.16
  3. Andrew Mark Haydon · 1 shared paper, 2023 · strength 0.16
  4. Matthew Burge · 1 shared paper, 2023 · strength 0.16
  5. Laëtitia Dahan · 1 shared paper, 2023 · strength 0.14
  6. John H. Strickler · 1 shared paper, 2023 · strength 0.14
  7. David Lawrence Bajor · 1 shared paper, 2023 · strength 0.14
  8. Antoine Hollebecque · 1 shared paper, 2023 · strength 0.14
  9. Andrew L. Coveler · 1 shared paper, 2023 · strength 0.14
  10. Yu Sunakawa · 1 shared paper, 2023 · strength 0.14
  11. Thomas J. George · 1 shared paper, 2023 · strength 0.14
  12. Rona D. Yaeger · 1 shared paper, 2023 · strength 0.14
  13. David S. Hong · 1 shared paper, 2023 · strength 0.14
  14. Ignacio Garrido‐Laguna · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.